What is the current Price Target for the Mereo BioPharma Group plc Sponsored ADR stock?

The average Mereo BioPharma Group plc Sponsored ADR target price is $1.53. This is 404.95% higher than the current stock price. The highest price target is 939.60%, the lowest is 66.67%. 8 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2027 .

How high will the Mereo BioPharma Group plc Sponsored ADR stock rise?

No reliable answer can be given as to how high the Mereo BioPharma Group plc Sponsored ADR stock will rise. The performance of stocks, including the Mereo BioPharma Group plc Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Mereo BioPharma Group plc Sponsored ADR stock today?

The performance of Mereo BioPharma Group plc Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Mereo BioPharma Group plc Sponsored ADR stock fall?

The decline in Mereo BioPharma Group plc Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Mereo BioPharma Group plc Sponsored ADR Forecast, price target & analysts

$0.30

4.45%

Nasdaq, Sep 18, 04:28 pm EDT. Closed.

ISIN

US5894921072

Symbol

MREO

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Mereo BioPharma Group plc Sponsored ADR Target price 2026 - Analyst rating & recommendation

Mereo BioPharma Group plc Sponsored ADR Classifications & Recommendation

Buy

71%

Hold

21%

Sell

Mereo BioPharma Group plc Sponsored ADR Price Target

Target Price	$1.53
Price	$0.30
Potential	404.95% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Mereo BioPharma Group plc Sponsored ADR 2027 . The average Mereo BioPharma Group plc Sponsored ADR target price is $1.53. This is 404.95% register free of charge higher than the current stock price. The highest price target is $3.15 939.60% register free of charge , the lowest is $0.51 66.67% register free of charge .
	A rating was issued by 14 analysts: 10 Analysts recommend Mereo BioPharma Group plc Sponsored ADR to buy, 3 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Mereo BioPharma Group plc Sponsored ADR stock has an average upside potential 2027 of 404.95% register free of charge . Most analysts recommend the Mereo BioPharma Group plc Sponsored ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-0.05	-0.04
	16.67%	20.00%
P/E		negative

9 Analysts have issued a Mereo BioPharma Group plc Sponsored ADR forecast for earnings per share. The average Mereo BioPharma Group plc Sponsored ADR EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-0.05	16.67%
2026	$-0.04 20.00% unlock
2027	$-0.04 0.00% unlock
2028	$-0.06 50.00% unlock
2029	$-0.04 33.33% unlock
2030	$0.02 150.00% unlock
2031	$0.08 300.00% unlock
2032	$0.14 75.00% unlock
2033	$0.21 50.00% unlock

Current	-10.10	61.78%
2026	-8.49 15.94% unlock
2027	-7.43 12.49% unlock
2028	-4.95 33.38% unlock
2029	-7.45 50.51% unlock
2030	19.94 367.65% unlock
2031	3.96 80.14% unlock
2032	2.12 46.46% unlock
2033	1.41 33.49% unlock

Mereo BioPharma Group plc Sponsored ADR...

Current Mereo BioPharma Group plc Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
JP Morgan	Locked ➜ Locked	Locked	Aug 19 2026
Needham	Locked ➜ Locked	Locked	Aug 11 2026
BTIG	Locked ➜ Locked	Locked	Aug 11 2026
BTIG	Locked ➜ Locked	Locked	May 12 2026
JP Morgan	Locked ➜ Locked	Locked	Mar 23 2026
BTIG	Locked ➜ Locked	Locked	Jan 16 2026
Needham	Locked ➜ Locked	Locked	Jan 13 2026

Analyst Rating	Date
Locked JP Morgan: Locked ➜ Locked	Aug 19 2026
Locked Needham: Locked ➜ Locked	Aug 11 2026
Locked BTIG: Locked ➜ Locked	Aug 11 2026
Locked BTIG: Locked ➜ Locked	May 12 2026
Locked JP Morgan: Locked ➜ Locked	Mar 23 2026
Locked BTIG: Locked ➜ Locked	Jan 16 2026
Locked Needham: Locked ➜ Locked	Jan 13 2026

Discover more stocks with a high price target

NIO ADR 100.10%

Alibaba Group Holding Ltd 68.75%

Infineon 65.25%

Tencent Holdings Ltd. 63.10%

Rheinmetall 61.30%

TUI 56.70%

Adyen 53.16%

Siemens Energy 49.14%

Adidas 46.64%

Uber Technologies 46.13%

BYD 40.95%

NVIDIA 37.67%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now